CoChat

The mycobacterial cell envelope — a moving target

Dulberger, Charles L., Rubin, Eric J., Boutte, Cara C. · 2020 · Nature Reviews Microbiology

The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index; 98 of the 127 sources its claims cite were checked for support.

Abstract

Mycobacterium tuberculosis, the leading cause of death due to infection, has a dynamic and immunomodulatory cell envelope. The cell envelope structurally and functionally varies across the length of the cell and during the infection process. This variability allows the bacterium to manipulate the human immune system, tolerate antibiotic treatment and adapt to the variable host environment. Much of what we know about the mycobacterial cell envelope has been gleaned from model actinobacterial species, or model conditions such as growth in vitro, in macrophages and in the mouse. In this Review, we combine data from different experimental systems to build a model of the dynamics of the mycobacterial cell envelope across space and time. We describe the regulatory pathways that control metabolism of the cell wall and surface lipids in M. tuberculosis during growth and stasis, and speculate about how this regulation might affect antibiotic susceptibility and interactions with the immune system.

Overview

CoChat Summary

TL;DR

This Review synthesizes data from model mycobacterial systems to argue that the *Mycobacterium tuberculosis* cell envelope is a spatially and temporally dynamic structure whose composition shifts between active growth and growth stasis. The authors propose that these envelope changes modulate immune interactions and antibiotic susceptibility, and that targeting stasis-active cell wall processes could shorten treatment.

Key findings

  • The envelope is spatially organized: mycobacteria lack MreB and elongate asymmetrically at the poles (old pole growing faster), with d–d peptidoglycan crosslinks at poles/septum and more l–d crosslinks mid-cell; daughter cells differ in growth rate, size and macromolecule distribution.
  • The authors model a growth-to-stasis shift in envelope composition: during active growth, peptidoglycan, arabinogalactan, mycolic acid metabolism, PIMs, TDM/TMM and PDIM are relatively abundant; in stasis, core wall metabolism decreases and shifts toward remodelling, PIMs/TDM/TMM/PDIM decrease, and LMs and LAMs become abundant.
  • Regulatory control is kinase-centric: PknB is described as the master upstream regulator of peptidoglycan metabolism during growth (acting via CwlM–MurA, MviN–FhaA and PonA1), while its transcriptional downregulation in stationary phase, starvation and hypoxia is linked to reduced wall permeability and increased antibiotic tolerance; PonA1 complexes are proposed to dominate in active growth and PonA2 complexes in stasis.
  • The mycomembrane makes the envelope 100–1,000 times less permeable to β-lactam antibiotics than the Gram-negative envelope; oxygenated meromycolates promote rifampicin tolerance in biofilms and increase resistance to several antibiotics, whereas cis-cyclopropanes have no effect or slightly promote sensitivity.

Methods

  • Narrative Review combining data from different experimental systems (in vitro culture, macrophage infection, mouse, guinea pig and primate models, plus sputum and explanted human lung samples) to build a model of cell envelope dynamics across space and time.
  • The authors state three simplifying assumptions: (1) *M. tuberculosis* shows two broad behaviours — rapid growth and growth stasis; (2) early infection can be modelled by in vitro stressors at sub-growth-blocking concentrations, early mouse infection and macrophage experiments; (3) stasis (growth and death in equilibrium, not arrested growth) can be modelled by chronic mouse infection and in vitro starvation, late stationary phase and oxygen deprivation.
  • No primary data collection or statistical analysis is reported; the work interprets published biochemical, structural, transcriptional, transposon-sequencing and infection data.

Limitations

  • Stated: it is "extremely difficult to study bacterial physiology during human infection"; available human material (sputum, explanted lungs) represents narrow subpopulations, and tools to study cell wall remodelling in these samples are very limited; in vitro and animal models cannot replicate the variability of human infection progression.
  • Stated: ultrastructure and protein localization studies are mostly limited to logarithmic-phase culture, so it is not possible to say how spatial organization and asymmetry differ under infection stresses.
  • Evident from the text: many conclusions are explicitly speculative ("we predict", "we propose", "in our model"), and the authors note that mechanisms of division site selection are poorly understood with conflicting observations, and that how *M. tuberculosis* uses asymmetric growth and remodelling during different infection stages is unknown.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41579-019-0273-7

Cites

160 of 160 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

52 Valid · 6 Not valid · 14 Not checked · 20 Own results and interpretations

38 more claims · 21 with their cited sources checked

Create a free account to see all 92 claims and to verify the 2 references still open.

See all claims — free account
  • It may state two separate claims as one. 47
  • Probably not a substantial claim. 3

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 160 references

Cited by

See all 366

Metadata

Authors
Dulberger, C. L., Rubin, E. J., & Boutte, C. C.
Affiliations
  • Harvard University (US)
  • The University of Texas at Arlington (US)
Corresponding author
Boutte, Cara C.
Venue
Nature Reviews Microbiology
Published
2019-11-14
Volume
18
Issue
1
Pages
47-59
ISSN
  • 1740-1526 (ISSN-L)
  • 1740-1534
OpenAlex
W2986825963
Cited by
365
References
160
Citations by year
2026: 50 · 2025: 75 · 2024: 48 · 2023: 55 · 2022: 48 · 2021: 49 · 2020: 39 · 2019: 1
FWCI
4.78
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Nature Reviews Microbiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of General Medical Sciences (R15GM131317)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
Keywords
Mycobacterium tuberculosis, mycobacterial cell envelope, cell wall metabolism, surface lipids, immune evasion, antibiotic resistance, antibiotic susceptibility, host adaptation, macrophages, tuberculosis infection
MeSH terms
Animals, Cell Wall, Drug Tolerance, Humans, Immunity, Innate, Mycobacterium tuberculosis, Lipid Metabolism, Host-Pathogen Interactions, Adaptive Immunity, Immune Evasion

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The mycobacterial cell envelope — a moving target. https://app.cochat.ai/papers/10.1038/s41579-019-0273-7
The paper
Dulberger, C. L., Rubin, E. J., & Boutte, C. C. (2020). The mycobacterial cell envelope — a moving target. Nature Reviews Microbiology. https://doi.org/10.1038/s41579-019-0273-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.